NCT02475070View on ClinicalTrials.gov

Vildagliptin Versus Dapagliflozin on Glucagon

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Type 2 Diabetes
Interventions
DRUG

Vildagliptin

Vildagliptin added at 50 mg twice daily for two weeks followed by four weeks washout and then dapagliflozin 10mg once daily for two weeks

DRUG

Dapagliflozin

Dapagliflozin added at 10 mg once daily for two weeks followed by four weeks washout and then vildagliptin 50 mg twice daily for two weeks

Trial Locations (1)

22184

Lund University, Lund

All Listed Sponsors
lead

Lund University

OTHER

NCT02475070 - Vildagliptin Versus Dapagliflozin on Glucagon | Biotech Hunter | Biotech Hunter